Articles by Moe Alsumidaie - Applied Clinical Trials

ADVERTISEMENT

Articles by Moe Alsumidaie

Moe Alsumidaie


Articles
The Future of Subject Enrollment: Aggregated EMR
July 29, 2014

The topic of subject enrollment has been evaluated from many different perspectives.

FDA Sentinel: Catching Biopharmaceutical Sponsors by Surprise
July 24, 2014

This article will discuss FDA's post-marketing surveillance programs, and how biopharmaceutical sponsors can work with the FDA to identify unreported Adverse Events.

Highlights from the 2014 DIA Annual Meeting in San Diego
June 26, 2014

DIA held its 2014 annual meeting in San Diego and attracted thousands of attendees from around the globe.

FDA's Margaret Hamburg: Angle on Patient Engagement and Regulatory Systems Reform
June 10, 2014

While at the 2014 New York BIO conference, FDA Commissioner, Dr. Margaret Hamburg, had the opportunity to address pressing issues affecting the biopharmaceutical industry and the FDA.

Interview with Nathan Tinker - Executive Director at the New York Biotechnology Association
June 2, 2014

While at the 2014 New York BIO Conference, I had the opportunity to interview Nathan Tinker, Executive Director at the New York Biotechnology Association, about challenges in early phase development.

Event Examines Key Clinical Trial Adaptation Trends
June 1, 2014

Clinical trial optimization through adaptation in several key areas was a prevailing message at the recent Partnerships Conference.

Highlights from the NewYorkBIO Conference: FDA Commissioner Hamburg Speaks
May 22, 2014

Investments, acquisitions in biotechnology, valuation, and regulatory innovation were main themes at the 2014 NewYorkBIO Conference.

How Bristol-Myers Squibb is doing Risk-Based Monitoring
May 13, 2014

Thomas Verish, Group Director of Data Operations Services at Bristol-Myers Squibb, elaborated on their risk-based monitoring pilot.

How Data is Transforming Clinical Trials and Healthcare: An Interview with Ayasdi's Pek Lum
May 8, 2014

While at the 2014 Bio IT World conference, I had the opportunity to interview Pek Lum, Ayasdi's Chief Data Scientist.

Advertisement

ADVERTISEMENT

Untitled Document
Click here